1
|
Braun J, Krüger K, Manger B, Schneider M,
Specker C and Trappe HJ: Cardiovascular comorbidity in inflammatory
rheumatological conditions. Dtsch Arztebl Int. 114:197–203.
2017.PubMed/NCBI View Article : Google Scholar
|
2
|
Dawi J, Affa S, Misakyan Y, Fardeheb S,
Kades S, Kiriaki A, Mohan AS, Norris B, Yoon S and Venketaraman V:
Exploring cardiovascular implications in systemic lupus
erythematosus: A holistic analysis of complications, diagnostic
criteria, and therapeutic modalities, encompassing pharmacological
and adjuvant approaches. Biomol Concepts. 15:2024.PubMed/NCBI View Article : Google Scholar
|
3
|
Miner JJ and Kim AH: Cardiac
manifestations of systemic lupus erythematosus. Rheum Dis Clin
North Am. 40:51–60. 2014.PubMed/NCBI View Article : Google Scholar
|
4
|
Schermuly RT, Ghofrani HA, Wilkins MR and
Grimminger F: Mechanisms of disease: Pulmonary arterial
hypertension. Nat Rev Cardiol. 8:443–455. 2011.PubMed/NCBI View Article : Google Scholar
|
5
|
Wigley FM, Lima JAC, Mayes M, McLain D,
Chapin JL and Ward-Able C: The prevalence of undiagnosed pulmonary
arterial hypertension in subjects with connective tissue disease at
the secondary health care level of community-based rheumatologists
(the UNCOVER study). Arthritis Rheum. 52:2125–2132. 2005.PubMed/NCBI View Article : Google Scholar
|
6
|
Plazak W, Gryga K, Milewski M, Podolec M,
Kostkiewicz M, Podolec P and Musial J: Association of heart
structure and function abnormalities with laboratory findings in
patients with systemic lupus erythematosus. Lupus. 20:936–944.
2011.PubMed/NCBI View Article : Google Scholar
|
7
|
Hassoun PM: The right ventricle in
scleroderma (2013 grover conference series). Pulm Circ. 5:3–14.
2015.PubMed/NCBI View
Article : Google Scholar
|
8
|
Alpert MA, Goldberg SH, Singsen BH, Durham
JB, Sharp GC, Ahmad M, Madigan NP, Hurst DP and Sullivan WD:
Cardiovascular manifestations of mixed connective tissue disease in
adults. Circulation. 68:1182–1193. 1983.PubMed/NCBI View Article : Google Scholar
|
9
|
Vegh J, Hegedus I, Szegedi G, Zeher M and
Bodolay E: Diastolic function of the heart in mixed connective
tissue disease. Clin Rheumatol. 26:176–181. 2007.PubMed/NCBI View Article : Google Scholar
|
10
|
Leal GN, Silva KF, França CMP, Lianza AC,
Andrade JL, Campos LMA, Bonfá E and Silva CA: Subclinical right
ventricle systolic dysfunction in childhood-onset systemic lupus
erythematosus: Insights from two-dimensional speckle-tracking
echocardiography. Lupus. 24:613–620. 2015.PubMed/NCBI View Article : Google Scholar
|
11
|
Kawut SM, Barr RG, Lima JAC, Praestgaard
A, Johnson WC, Chahal H, Ogunyankin KO, Bristow MR, Kizer JR,
Tandri H and Bluemke DA: Right ventricular structure is associated
with the risk of heart failure and cardiovascular death: The
Multi-Ethnic Study of Atherosclerosis (MESA)-right ventricle study.
Circulation. 126:1681–1688. 2012.PubMed/NCBI View Article : Google Scholar
|
12
|
Tang Y, Yang Z, Wen J, Tang D, Luo Y,
Xiang C, Huang L and Xia L: Association of serum uric acid with
right cardiac chamber remodeling assessed by cardiovascular
magnetic resonance feature tracking in patients with connective
tissue disease. Front Endocrinol (Lausanne).
15(1351197)2024.PubMed/NCBI View Article : Google Scholar
|
13
|
Vos JL, Butcher SC, Fortuni F, Galloo X,
Rodwell L, Vonk MC, Bax JJ, van Leuven SI, de Vries-Bouwstra JK,
Snoeren M, et al: The prognostic value of right atrial and right
ventricular functional parameters in systemic sclerosis. Front
Cardiovasc Med. 9(845359)2022.PubMed/NCBI View Article : Google Scholar
|
14
|
Rich S, Pogoriler J, Husain AN, Toth PT,
Gomberg-Maitland M and Archer SL: Long-term effects of epoprostenol
on the pulmonary vasculature in idiopathic pulmonary arterial
hypertension. Chest. 138:1234–1239. 2010.PubMed/NCBI View Article : Google Scholar
|
15
|
Bell RD, White RJ, Garcia-Hernandez ML, Wu
E, Rahimi H, Marangoni RG, Slattery P, Duemmel S, Nuzzo M, Huertas
N, et al: Tumor necrosis factor induces obliterative pulmonary
vascular disease in a novel model of connective tissue
disease-associated pulmonary arterial hypertension. Arthritis
Rheumatol. 72:1759–1770. 2020.PubMed/NCBI View Article : Google Scholar
|
16
|
Messroghli DR, Moon JC, Ferreira VM,
Grosse-Wortmann L, He T, Kellman P, Mascherbauer J, Nezafat R,
Salerno M, Schelbert EB, et al: Clinical recommendations for
cardiovascular magnetic resonance mapping of T1, T2, T2* and
extracellular volume: A consensus statement by the society for
cardiovascular magnetic resonance (SCMR) endorsed by the European
association for cardiovascular imaging (EACVI). J Cardiovasc Magn
Reson. 19(75)2017.PubMed/NCBI View Article : Google Scholar
|
17
|
White SK, Sado DM, Flett AS and Moon JC:
Characterising the myocardial interstitial space: The clinical
relevance of non-invasive imaging. Heart. 98:773–779.
2012.PubMed/NCBI View Article : Google Scholar
|
18
|
Wong TC, Piehler KM, Kang IA, Kadakkal A,
Kellman P, Schwartzman DS, Mulukutla SR, Simon MA, Shroff SG,
Kuller LH and Schelbert EB: Myocardial extracellular volume
fraction quantified by cardiovascular magnetic resonance is
increased in diabetes and associated with mortality and incident
heart failure admission. Eur Heart J. 35:657–664. 2014.PubMed/NCBI View Article : Google Scholar
|
19
|
Broberg CS, Chugh SS, Conklin C, Sahn DJ
and Jerosch-Herold M: Quantification of diffuse myocardial fibrosis
and its association with myocardial dysfunction in congenital heart
disease. Circ Cardiovasc Imaging. 3:727–734. 2010.PubMed/NCBI View Article : Google Scholar
|
20
|
Hachulla AL, Launay D, Gaxotte V, de
Groote P, Lamblin N, Devos P, Hatron PY, Beregi JP and Hachulla E:
Cardiac magnetic resonance imaging in systemic sclerosis: A
cross-sectional observational study of 52 patients. Ann Rheum Dis.
68:1878–1884. 2009.PubMed/NCBI View Article : Google Scholar
|
21
|
Mavrogeni S, Sfikakis PP, Karabela G,
Stavropoulos E, Spiliotis G, Gialafos E, Panopoulos S, Bournia V,
Manolopoulou D, Kolovou G and Kitas G: Cardiovascular magnetic
resonance imaging in asymptomatic patients with connective tissue
disease and recent onset left bundle branch block. Int J Cardiol.
171:82–87. 2014.PubMed/NCBI View Article : Google Scholar
|
22
|
Zhernakova A, van Diemen CC and Wijmenga
C: Detecting shared pathogenesis from the shared genetics of
immune-related diseases. Nat Rev Genet. 10:43–55. 2009.PubMed/NCBI View
Article : Google Scholar
|
23
|
Rudski LG, Lai WW, Afilalo J, Hua L,
Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK and
Schiller NB: Guidelines for the echocardiographic assessment of the
right heart in adults: A report from the American society of
echocardiography endorsed by the European association of
echocardiography, a registered branch of the European society of
cardiology, and the canadian society of echocardiography. J Am Soc
Echocardiogr. 23:685–713, 786-788. 2010.PubMed/NCBI View Article : Google Scholar
|
24
|
Humbert M, Kovacs G, Hoeper MM,
Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS,
Escribano-Subias P, Ferrari P, et al: 2022 ESC/ERS guidelines for
the diagnosis and treatment of pulmonary hypertension. Eur Heart J.
43:3618–3731. 2022.PubMed/NCBI View Article : Google Scholar
|
25
|
Altmayer SPL, Patel AR, Addetia K,
Gomberg-Maitland M, Forfia PR and Han Y: Cardiac MRI right
ventricle/left ventricle (RV/LV) volume ratio improves detection of
RV enlargement. J Magn Reson Imaging. 43:1379–1385. 2016.PubMed/NCBI View Article : Google Scholar
|
26
|
Minegishi S, Kato S, Takase-Minegishi K,
Horita N, Azushima K, Wakui H, Ishigami T, Kosuge M, Kimura K and
Tamura K: Native T1 time and extracellular volume fraction in
differentiation of normal myocardium from non-ischemic dilated and
hypertrophic cardiomyopathy myocardium: A systematic review and
meta-analysis. Int J Cardiol Heart Vasc. 25(100422)2019.PubMed/NCBI View Article : Google Scholar
|
27
|
Hsu S, Houston BA, Tampakakis E, Bacher
AC, Rhodes PS, Mathai SC, Damico RL, Kolb TM, Hummers LK, Shah AA,
et al: Right ventricular functional reserve in pulmonary arterial
hypertension. Circulation. 133:2413–2422. 2016.PubMed/NCBI View Article : Google Scholar
|
28
|
Li X, Shi K, Yang ZG, Guo YK, Huang S, Xia
CC, He S, Li ZL, Li C and He Y: Assessing right ventricular
deformation in hypertrophic cardiomyopathy patients with preserved
right ventricular ejection fraction: A 3.0-T cardiovascular
magnetic resonance study. Sci Rep. 10(1967)2020.PubMed/NCBI View Article : Google Scholar
|
29
|
Konstam MA, Kiernan MS, Bernstein D,
Bozkurt B, Jacob M, Kapur NK, Kociol RD, Lewis EF, Mehra MR, Pagani
FD, et al: Evaluation and management of right-sided heart failure:
A scientific statement from the American heart association.
Circulation. 137:e578–e622. 2018.PubMed/NCBI View Article : Google Scholar
|
30
|
Monteagudo-Vela M, Tindale A,
Monguió-Santín E, Reyes-Copa G and Panoulas V: Right ventricular
failure: Current strategies and future development. Front
Cardiovasc Med. 10(998382)2023.PubMed/NCBI View Article : Google Scholar
|
31
|
Ryan JJ and Archer SL: The right ventricle
in pulmonary arterial hypertension: Disorders of metabolism,
angiogenesis and adrenergic signaling in right ventricular failure.
Circ Res. 115:176–188. 2014.PubMed/NCBI View Article : Google Scholar
|
32
|
Mascherbauer J, Marzluf BA, Tufaro C,
Pfaffenberger S, Graf A, Wexberg P, Panzenböck A, Jakowitsch J,
Bangert C, Laimer D, et al: Cardiac magnetic resonance postcontrast
T1 time is associated with outcome in patients with heart failure
and preserved ejection fraction. Circ Cardiovasc Imaging.
6:1056–1065. 2013.PubMed/NCBI View Article : Google Scholar
|
33
|
Puntmann VO, Voigt T, Chen Z, Mayr M,
Karim R, Rhode K, Pastor A, Carr-White G, Razavi R, Schaeffter T
and Nagel E: Native T1 mapping in differentiation of normal
myocardium from diffuse disease in hypertrophic and dilated
cardiomyopathy. JACC Cardiovasc Imaging. 6:475–484. 2013.PubMed/NCBI View Article : Google Scholar
|
34
|
Yeong CC, Harrop DL, Ng ACT and Wang WYS:
Global longitudinal strain manually measured from mid-myocardial
lengths is a reliable alternative to speckle tracking global
longitudinal strain. J Cardiovasc Imaging. 32(35)2024.PubMed/NCBI View Article : Google Scholar
|
35
|
Seno A, Antiochos P, Lichtenfeld H,
Rickers E, Qamar I, Ge Y, Blankstein R, Steigner M, Aghayev A,
Jerosch-Herold M and Kwong RY: Prognostic value of T1 mapping and
feature tracking by cardiac magnetic resonance in patients with
signs and symptoms suspecting heart failure and no clinical
evidence of coronary artery disease. J Am Heart Assoc.
11(e020981)2022.PubMed/NCBI View Article : Google Scholar
|
36
|
Korthals D, Chatzantonis G, Bietenbeck M,
Meier C, Stalling P and Yilmaz A: CMR-based T1-mapping offers
superior diagnostic value compared to longitudinal strain-based
assessment of relative apical sparing in cardiac amyloidosis. Sci
Rep. 11(15521)2021.PubMed/NCBI View Article : Google Scholar
|